Sorrento intends to combine a variety of its proprietary mAbs in conjunction with the ADNAB technology platform... Apr 28
The number of active cases of COVID-19 is continuously declining. Currently, four thousand 156 patients are receiving treatment at various hospitals in Bihar. ... Jan 07
Serum Institute Of India And Dynavax, today jointly announced that the first participants have been dosed in the Phase 1 part of the Phase 1/... Dec 24
MASITINIB DEMONSTRATED SIGNIFICANT EFFECT ON BOTH COGNITION, MEASURED WITH ADAS-COG, AND DAILY ACTIVITY, MEASURED WITH ADCS-ADL... Dec 16
ViralClear Pharmaceuticals, Inc. announced the halting of its signal finding Phase 2 hospitalized Covid-19 trial.... Oct 27
In this study, the addition of nelonemdaz to surgical blood clot removal improved a patient’s chances of returning to functional independence 90 days later.... Oct 15
After, Covishield's first shot, tests related to COVID-19 and antibodies came negative, officials said... Aug 27
South Korea, desperate for Covid drug skips phase 1 trial... Aug 20
During 2018 and 2019, BaseLaunch supported nine early therapeutic ventures and raised more than USD 100 million ... May 23
-Advertisements-
Wednesday, May 15, 2024
.jpeg)
